Part 4: Today’s Most Promising Drug Targets
43 Experts Weigh in on the Most Promising Disease-Modifying Therapies in PD
Author: Benjamin
Part 3: A Crash Course in Drug Development
The Most Important Hurdles To Getting a Drug to Market
Part 2: Coping with Biology
Lessons from the Microscopic World Around Us
The Search for a Cure – Part 1: Back to the Future
What the PD World is Working on
Interview with Musician and Neuroscientist Prof. David Sulzer
on Elephants, Intelligence, Neuromelanin, Regrowing Neurons and more
Interview With Former Pharmaceutical Executive Dr. Kalpana Merchant
on The Divide Between Academia and Industry, Speeding Up Therapeutic Development, and more
Triggers, Facilitators and Aggravators: A New Hypothesis of Parkinson’s disease
Connecting the Dots in Parkinson’s Research
It’s The Environment, Stupid
Featuring an Interview with Environmental Epidemiologist Prof. Honglei Chen
Notes From a Behind the Scenes Look at Roche
The Role of Big Pharma and the Quest for a Cure
Cell Replacement Therapy Experts Survey
Experts Weigh in on Some of the Biggest Unresolved Questions Facing the Future of Cell Therapy
